ZETA has opened a location in Singapore, as a new service offering for the Asian market.
The Austrian company with core competencies in engineering, plant construction, automation, digitisation, HVAC and cleanroom design has established itself internationally as a one-stop-shop for the biopharmaceutical industry. With the opening of its new subsidiary in Singapore, Asian companies in the pharmaceutical and biotech industries can now also benefit from customer-specific services on-site.
We see ourselves as a one-stop-shop that, in addition to planning, design, development, manufacturing, automation, digitisation, and maintenance of customer-specific aseptic process solutions, also combines the planning of HVAC and cleanroom technology under one roof
Risk and complexity management in manufacturing biopharmaceutical products are central challenges confronting companies in this industry. As an engineering specialist for biopharmaceutical process plants, ZETA reduces interfaces in a targeted manner, enabling a significant reduction in project lead times. This is an innovative approach from which Asian companies can now also benefit from the new Singapore subsidiary.
What are they offering?
ZETA's services are not only valued by long-term partners in Europe. Big pharma on the international market also rely on the extensive expertise of ZETA experts. ZETA supports customers along the entire drug development and manufacturing process with sophisticated solutions from the laboratory to industrial production.
"We see ourselves as a one-stop-shop that, in addition to planning, design, development, manufacturing, automation, digitisation, and maintenance of customer-specific aseptic process solutions, also combines the planning of HVAC and cleanroom technology under one roof. We are actively contributing to the rapid market launch and market supply of life-saving active ingredients through this integrated approach," said Andreas Marchler, Managing Director of the ZETA Group.
Customised services for Asia
With its new subsidiary in Singapore, ZETA intensifies its business activities in Asia. "The biopharmaceutical market in Asia is growing rapidly. Singapore, with its talent pool, infrastructure, and regional connectivity, is the natural choice for ZETA to establish a team of highly competent engineers capable of meeting our customer needs," emphasises Sushaant Bakhru, Managing Director of ZETA Singapore.
In recent years, numerous projects have been implemented with Asian customers, such as the planning, construction, and automation of a USP production plant expansion in South Korea or DSP-Systems in Singapore.
The Singapore branch will now ensure even greater cooperation with these customers: "The Singapore office marks an important step for ZETA's presence in the region, positioning us as a truly global player in the industry. Being closer to customers will allow us to be flexible and agile in responding to their requests," Bakhru points out.